Qualigen Therapeutics, Inc. (QLGN) Financials
QLGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 4.3 million | 6.0 million |
2023-06-30 | 13.1 million | 9.8 million |
2023-03-31 | 19.1 million | 10.3 million |
2022-12-31 | 19.1 million | 10.3 million |
QLGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 1.2 million | 122696 |
2023-06-30 | -3.0 million | 653919 |
2023-03-31 | -2.5 million | 1.4 million |
2022-12-31 | -2.5 million | 1.4 million |
QLGN Net Income
No data available :(
QLGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 2.1 million | - | - |
2023-06-30 | 1.3 million | - | 1.4 million |
2023-03-31 | 7.0 million | - | 1.5 million |
2022-12-31 | - | - | 1.7 million |
QLGN Shares Outstanding
QLGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 246418 | 1.4 million | 1.3 million | - |
2023-06-30 | 48409 | 1.3 million | 2.7 million | 169223 |
2023-03-31 | 244374 | 1.8 million | 2.7 million | 267129 |
2022-12-31 | 244374 | 1.8 million | 2.9 million | - |
QLGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | 1.6 million | 1.0 million |
2023-03-31 | 1.4 million | 1.1 million |
2022-12-31 | 1.4 million | 1.1 million |
QLGN
Price: $0.30
52 week price:
Earnings Per Share: -4.07 USD
P/E Ratio: -0.13
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 69100
Market Capitalization: 1.9 million